REGENXBIO to Participate in Global Healthcare Conferences
Sep 07, 2016 20:01 pm UTC| Business
ROCKVILLE, Md., Sept. 07, 2016 -- REGENXBIO Inc. (Nasdaq:RGNX), a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy based...
Forward Signs New Three Year Supplier Agreement With Global Healthcare Provider
Sep 07, 2016 20:01 pm UTC| Business
WEST PALM BEACH, Fla., Sept. 07, 2016 -- Forward Industries, Inc. (NASDAQ:FORD), a designer and distributor of custom carry and protective solutions, today announced that they have signed a new 3 year agreement with a...
DAVIDsTEA Inc. Announces Second Quarter Fiscal 2016 Financial Results
Sep 07, 2016 20:01 pm UTC| Business
Second quarter sales growth of 25.3% to C$41.1 million; comparable sales increase of 5.1% Reiterates Fiscal 2016 outlook MONTREAL, Sept. 07, 2016 -- DAVIDsTEA Inc. (Nasdaq:DTEA) today announced financial results for...
Sep 07, 2016 20:01 pm UTC| Business
Subjects with moderate to severe endometriosis experienced relief of menstrual pain and a reduction in the use of pain medication with the use of Proellex® Proellex® subjects’ menstrual pain by BBSS decreased significantly...
Bazaarvoice, Inc. Announces its Financial Results for the First Fiscal Quarter of 2017
Sep 07, 2016 20:01 pm UTC| Business
First fiscal quarter highlights include: Delivered Q1 revenue of$50.1 million, up 2.5% from the same period a year agoAchieved positive operating cash flow for the fourth quarter in a rowImproved GAAP net loss to $5.1...
Park City Group Reports Record Fiscal 4Q and Full-Year 2016 Results
Sep 07, 2016 20:01 pm UTC| Business
Reached inflection point with record fiscal 4Q revenue and rising GAAP profitability.Achieved 4x increase in ReposiTrak connections with more than 10,000 at fiscal year-end. Significant acceleration expected in fiscal 2017...
Avinger Signs Agreement with HealthTrust for Lumivascular Technology
Sep 07, 2016 20:01 pm UTC| Business
REDWOOD CITY, Calif., Sept. 07, 2016 -- Avinger, Inc. (NASDAQ:AVGR), a developer of innovative treatments for peripheral artery disease (PAD), today announced it has signed an agreement with HealthTrust. The agreement...
Trump Says Ukraine Peace Deal ‘Closer,’ But Key Disputes Remain Unresolved